These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 364937)

  • 1. Oxygen reduction by the P450 monoxygenase systems.
    Gunsalus IC; Sligar SG
    Adv Enzymol Relat Areas Mol Biol; 1978; 47():1-44. PubMed ID: 364937
    [No Abstract]   [Full Text] [Related]  

  • 2. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
    Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
    Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
    [No Abstract]   [Full Text] [Related]  

  • 3. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aniline hydroxylase and nitroreductase activities of partially purified cytochromes P-450 and P-420, and cytochrome b5 solubilized from rabbit hepatic microsomes.
    Symms KG; Juchau MR
    Drug Metab Dispos; 1974; 2(2):194-201. PubMed ID: 4151000
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxygen activation by cytochrome P-450.
    White RE; Coon MJ
    Annu Rev Biochem; 1980; 49():315-56. PubMed ID: 6996566
    [No Abstract]   [Full Text] [Related]  

  • 6. NADPH cytochrome P-450 reductase and its role in the mixed function oxidase reaction.
    Strobel HW; Dignam JD; Gum JR
    Pharmacol Ther; 1980; 8(3):525-37. PubMed ID: 6770379
    [No Abstract]   [Full Text] [Related]  

  • 7. Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.
    Hudeèek J; Baumruk V; Anzenbacher P; Munro AW
    Biochem Biophys Res Commun; 1998 Feb; 243(3):811-5. PubMed ID: 9500975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol side-chain cleavage, cytochrome P450, and iron-sulfur protein in human placental mitochondria.
    Simpson ER; Miller DA
    Arch Biochem Biophys; 1978 Oct; 190(2):800-8. PubMed ID: 214040
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of molecular oxygen by flavins and flavoproteins.
    Massey V
    J Biol Chem; 1994 Sep; 269(36):22459-62. PubMed ID: 8077188
    [No Abstract]   [Full Text] [Related]  

  • 10. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA; Roman LJ; Miller RT; Masters BS
    Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The final step of aldosterone biosynthesis is catalyzed by an NADPH-dependent and molecular oxygen-requiring enzyme.
    Kojima I; Inano H; Tamaoki B
    Biochem Biophys Res Commun; 1982 May; 106(2):617-24. PubMed ID: 7104011
    [No Abstract]   [Full Text] [Related]  

  • 12. Probing inter-domain electron transfer in a model flavocytochrome P-450.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S629. PubMed ID: 9450057
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reevaluation of the role of cytochrome P-450 as the terminal oxidase in hepatic microsomal mixed function oxidase catalyzed reactions.
    Cooper DY; Schleyer H; Levin SS; Eisenhardt RH; Novack BG; Rosenthal O
    Drug Metab Rev; 1979; 10(2):153-85. PubMed ID: 399457
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 16. A unified mechanistic view of oxidative reactions catalysed by P-450 and related Fe-containing enzymes.
    Akhtar M; Wright JN
    Nat Prod Rep; 1991 Dec; 8(6):527-51. PubMed ID: 1784431
    [No Abstract]   [Full Text] [Related]  

  • 17. Stoichiometry of the mixed function oxidase.
    Powis G; Jansson I
    Pharmacol Ther; 1979; 7(2):297-311. PubMed ID: 42935
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
    Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
    J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectral properties of the oxyferrous complex of the heme domain of cytochrome P450 BM-3 (CYP102).
    Bec N; Anzenbacher P; Anzenbacherová E; Gorren AC; Munro AW; Lange R
    Biochem Biophys Res Commun; 1999 Dec; 266(1):187-9. PubMed ID: 10581187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
    Murataliev MB; Feyereisen R
    Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.